- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.19 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x FBP: 1,6-di-O-phosphono-beta-D-fructofuranose(Non-covalent)
- 13 x MG: MAGNESIUM ION(Non-covalent)(Non-functional Binders)
MG.2: 5 residues within 4Å:- Chain A: E.285, D.309
- Ligands: MG.5, ATP.6, OXL.7
2 PLIP interactions:2 interactions with chain A- Metal complexes: A:E.285, A:D.309
MG.3: 2 residues within 4Å:- Chain A: D.191
- Ligands: ATP.6
No protein-ligand interaction detected (PLIP)MG.4: 7 residues within 4Å:- Chain A: N.88, S.90, D.126, T.127, S.256, K.283
- Ligands: ATP.6
4 PLIP interactions:3 interactions with chain A, 1 Ligand-Water interactions- Metal complexes: A:S.90, A:D.126, A:T.127, H2O.2
MG.5: 6 residues within 4Å:- Chain A: R.133, D.191, G.221, D.309
- Ligands: MG.2, ATP.6
4 PLIP interactions:2 interactions with chain A, 2 Ligand-Water interactions- Metal complexes: A:D.309, A:D.309, H2O.3, H2O.9
MG.18: 4 residues within 4Å:- Chain B: E.285, D.309
- Ligands: ATP.22, OXL.23
2 PLIP interactions:2 interactions with chain B- Metal complexes: B:E.285, B:D.309
MG.19: 6 residues within 4Å:- Chain B: N.88, S.90, D.126, T.127, S.256
- Ligands: ATP.22
4 PLIP interactions:3 interactions with chain B, 1 Ligand-Water interactions- Metal complexes: B:S.90, B:D.126, B:T.127, H2O.18
MG.20: 2 residues within 4Å:- Chain B: D.191
- Ligands: ATP.22
No protein-ligand interaction detected (PLIP)MG.21: 5 residues within 4Å:- Chain B: R.133, D.191, G.221, D.309
- Ligands: ATP.22
4 PLIP interactions:2 interactions with chain B, 2 Ligand-Water interactions- Metal complexes: B:D.309, B:D.309, H2O.14, H2O.15
MG.35: 3 residues within 4Å:- Chain C: E.285, D.309
- Ligands: OXL.37
2 PLIP interactions:2 interactions with chain C- Metal complexes: C:E.285, C:D.309
MG.36: 5 residues within 4Å:- Chain C: N.88, S.90, D.126, T.127, S.256
5 PLIP interactions:3 interactions with chain C, 2 Ligand-Water interactions- Metal complexes: C:S.90, C:D.126, C:T.127, H2O.28, H2O.29
MG.48: 1 residues within 4Å:- Ligands: ATP.51
No protein-ligand interaction detected (PLIP)MG.49: 4 residues within 4Å:- Chain D: E.285, D.309
- Ligands: ATP.51, OXL.52
2 PLIP interactions:2 interactions with chain D- Metal complexes: D:E.285, D:D.309
MG.50: 7 residues within 4Å:- Chain D: N.88, S.90, D.126, T.127, S.256, K.283
- Ligands: ATP.51
4 PLIP interactions:3 interactions with chain D, 1 Ligand-Water interactions- Metal complexes: D:S.90, D:D.126, D:T.127, H2O.38
- 3 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
ATP.6: 24 residues within 4Å:- Chain A: T.63, I.64, P.66, R.86, N.88, H.91, Y.96, H.97, D.126, R.133, D.191, K.220, K.283, D.309, S.375, G.376, A.379, K.380
- Ligands: MG.2, MG.3, MG.4, MG.5, OXL.7, EDO.10
19 PLIP interactions:19 interactions with chain A- Hydrogen bonds: A:I.64, A:N.88, A:K.220, A:K.220, A:S.375
- Water bridges: A:G.92, A:R.133, A:D.190, A:K.220, A:S.256, A:G.376, A:K.380
- Salt bridges: A:R.86, A:R.86, A:H.91, A:R.133, A:R.133, A:K.283
- pi-Stacking: A:H.91
ATP.22: 23 residues within 4Å:- Chain B: T.63, I.64, P.66, R.86, N.88, H.91, Y.96, H.97, D.126, R.133, D.191, K.220, K.283, D.309, S.375, A.379, K.380
- Ligands: MG.18, MG.19, MG.20, MG.21, OXL.23, PGE.24
19 PLIP interactions:19 interactions with chain B- Hydrogen bonds: B:I.64, B:N.88, B:K.220, B:K.220
- Water bridges: B:R.86, B:R.86, B:R.133, B:R.133, B:R.133, B:D.190, B:S.256, B:G.376
- Salt bridges: B:R.86, B:R.86, B:H.91, B:R.133, B:R.133, B:K.283
- pi-Stacking: B:H.91
ATP.51: 21 residues within 4Å:- Chain D: T.63, I.64, P.66, R.86, N.88, H.91, Y.96, H.97, D.126, R.133, K.220, K.283, D.309, S.375, A.379, K.380
- Ligands: MG.48, MG.49, MG.50, OXL.52, EDO.54
21 PLIP interactions:21 interactions with chain D- Hydrogen bonds: D:I.64, D:N.88, D:D.126, D:K.220, D:K.220, D:S.375
- Water bridges: D:R.133, D:R.133, D:R.133, D:D.190, D:D.190, D:D.190, D:G.376, D:K.380
- Salt bridges: D:R.86, D:R.86, D:H.91, D:R.133, D:R.133, D:K.283
- pi-Stacking: D:H.91
- 4 x OXL: OXALATE ION(Non-covalent)
OXL.7: 12 residues within 4Å:- Chain A: R.86, K.283, E.285, M.304, A.306, R.307, G.308, D.309, T.341, M.373
- Ligands: MG.2, ATP.6
7 PLIP interactions:7 interactions with chain A- Hydrogen bonds: A:E.285, A:E.285, A:G.308, A:D.309
- Salt bridges: A:R.86, A:K.283, A:K.283
OXL.23: 12 residues within 4Å:- Chain B: R.86, K.283, E.285, M.304, A.306, R.307, G.308, D.309, T.341, M.373
- Ligands: MG.18, ATP.22
9 PLIP interactions:9 interactions with chain B- Hydrogen bonds: B:E.285, B:G.308, B:D.309, B:T.341, B:T.341
- Water bridges: B:R.86
- Salt bridges: B:R.86, B:K.283, B:K.283
OXL.37: 10 residues within 4Å:- Chain C: R.86, K.283, E.285, A.306, R.307, G.308, D.309, T.341, M.373
- Ligands: MG.35
9 PLIP interactions:9 interactions with chain C- Hydrogen bonds: C:G.308, C:D.309, C:T.341, C:T.341, C:T.341
- Water bridges: C:R.86
- Salt bridges: C:R.86, C:K.283, C:K.283
OXL.52: 12 residues within 4Å:- Chain D: R.86, K.283, E.285, M.304, A.306, R.307, G.308, D.309, T.341, M.373
- Ligands: MG.49, ATP.51
5 PLIP interactions:5 interactions with chain D- Hydrogen bonds: D:E.285, D:G.308, D:D.309
- Salt bridges: D:R.86, D:K.283
- 33 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.8: 5 residues within 4Å:- Chain A: A.55, R.56, H.392, F.483
- Ligands: EDO.11
Ligand excluded by PLIPEDO.9: 10 residues within 4Å:- Chain A: G.334, K.335, P.336, D.370, Q.452, S.455, Q.456, R.458, L.478, S.479
Ligand excluded by PLIPEDO.10: 6 residues within 4Å:- Chain A: H.91, P.141, S.218, R.219, K.220
- Ligands: ATP.6
Ligand excluded by PLIPEDO.11: 7 residues within 4Å:- Chain A: R.56, K.79, A.80, G.81, R.119, H.392
- Ligands: EDO.8
Ligand excluded by PLIPEDO.12: 5 residues within 4Å:- Chain A: R.352, P.353, R.355
- Chain B: D.191, G.192
Ligand excluded by PLIPEDO.13: 4 residues within 4Å:- Chain A: S.70, V.71, D.72, N.103
Ligand excluded by PLIPEDO.14: 1 residues within 4Å:- Chain A: N.249
Ligand excluded by PLIPEDO.25: 5 residues within 4Å:- Chain B: N.249, S.469, A.470, Q.471, R.474
Ligand excluded by PLIPEDO.26: 4 residues within 4Å:- Chain B: A.55, R.56, H.392, R.396
Ligand excluded by PLIPEDO.27: 2 residues within 4Å:- Chain B: L.541
- Chain D: W.528
Ligand excluded by PLIPEDO.28: 6 residues within 4Å:- Chain B: R.73, S.382, F.383, P.384, V.385, E.386
Ligand excluded by PLIPEDO.29: 5 residues within 4Å:- Chain B: V.222, N.223, L.224, V.229, E.313
Ligand excluded by PLIPEDO.30: 5 residues within 4Å:- Chain B: H.404, R.405, F.408, F.434
- Ligands: EDO.32
Ligand excluded by PLIPEDO.31: 4 residues within 4Å:- Chain A: M.389, M.390, A.393
- Chain B: E.317
Ligand excluded by PLIPEDO.32: 7 residues within 4Å:- Chain B: E.431, F.434, K.435
- Chain D: R.412, L.417, I.427
- Ligands: EDO.30
Ligand excluded by PLIPEDO.33: 7 residues within 4Å:- Chain B: R.468, P.491, W.495, D.498, R.502, P.530
- Ligands: FBP.17
Ligand excluded by PLIPEDO.38: 4 residues within 4Å:- Chain C: E.317
- Chain D: M.389, M.390, A.393
Ligand excluded by PLIPEDO.39: 7 residues within 4Å:- Chain C: R.56, K.79, A.80, G.81, R.119, H.392
- Ligands: EDO.40
Ligand excluded by PLIPEDO.40: 6 residues within 4Å:- Chain C: A.55, R.56, H.392, R.396, F.483
- Ligands: EDO.39
Ligand excluded by PLIPEDO.41: 5 residues within 4Å:- Chain C: R.352, P.353, R.355
- Chain D: D.191, G.192
Ligand excluded by PLIPEDO.42: 2 residues within 4Å:- Chain C: R.329
- Chain D: C.44
Ligand excluded by PLIPEDO.43: 6 residues within 4Å:- Chain C: T.63, R.86, N.88, H.91, S.375, A.379
Ligand excluded by PLIPEDO.44: 5 residues within 4Å:- Chain C: D.301, K.335, P.336, Q.452
- Ligands: EDO.45
Ligand excluded by PLIPEDO.45: 7 residues within 4Å:- Chain C: R.268, E.298, V.299, S.300, D.301, K.335
- Ligands: EDO.44
Ligand excluded by PLIPEDO.46: 4 residues within 4Å:- Chain C: P.421, W.528, Y.534
- Ligands: PG4.16
Ligand excluded by PLIPEDO.53: 5 residues within 4Å:- Chain B: R.412
- Chain D: R.405, F.408, R.412, F.434
Ligand excluded by PLIPEDO.54: 6 residues within 4Å:- Chain D: H.91, P.141, S.218, R.219, K.220
- Ligands: ATP.51
Ligand excluded by PLIPEDO.55: 9 residues within 4Å:- Chain D: G.334, K.335, P.336, D.370, Q.452, S.455, Q.456, R.458, S.479
Ligand excluded by PLIPEDO.56: 3 residues within 4Å:- Chain D: A.55, R.56, H.392
Ligand excluded by PLIPEDO.57: 3 residues within 4Å:- Chain D: V.71, E.106
- Ligands: PEG.61
Ligand excluded by PLIPEDO.58: 5 residues within 4Å:- Chain D: P.66, A.67, R.69, S.70, R.73
Ligand excluded by PLIPEDO.59: 5 residues within 4Å:- Chain D: N.249, S.469, A.470, Q.471, R.474
Ligand excluded by PLIPEDO.60: 5 residues within 4Å:- Chain D: V.222, N.223, L.224, V.229, E.313
Ligand excluded by PLIP- 2 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
PEG.15: 9 residues within 4Å:- Chain A: V.402, H.404, R.458, P.459, A.461, A.462, V.463, R.480, G.481
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:V.463, A:R.480, A:G.481
PEG.61: 5 residues within 4Å:- Chain D: S.70, V.71, D.72, N.103
- Ligands: EDO.57
3 PLIP interactions:3 interactions with chain D- Hydrogen bonds: D:V.71, D:D.72, D:D.72
- 1 x PG4: TETRAETHYLENE GLYCOL(Non-functional Binders)
- 1 x PGE: TRIETHYLENE GLYCOL(Non-functional Binders)
- 1 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Gassaway, B.M. et al., Distinct Hepatic PKA and CDK Signaling Pathways Control Activity-Independent Pyruvate Kinase Phosphorylation and Hepatic Glucose Production. Cell Rep (2019)
- Release Date
- 2019-12-04
- Peptides
- Pyruvate kinase PKLR: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.19 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x FBP: 1,6-di-O-phosphono-beta-D-fructofuranose(Non-covalent)
- 13 x MG: MAGNESIUM ION(Non-covalent)(Non-functional Binders)
- 3 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
- 4 x OXL: OXALATE ION(Non-covalent)
- 33 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 2 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- 1 x PG4: TETRAETHYLENE GLYCOL(Non-functional Binders)
- 1 x PGE: TRIETHYLENE GLYCOL(Non-functional Binders)
- 1 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Gassaway, B.M. et al., Distinct Hepatic PKA and CDK Signaling Pathways Control Activity-Independent Pyruvate Kinase Phosphorylation and Hepatic Glucose Production. Cell Rep (2019)
- Release Date
- 2019-12-04
- Peptides
- Pyruvate kinase PKLR: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D